Carsten Niemann, MD, PhD, is a Clinical Associate Professor and Principal Investigator at Rigshospitalet, Copenhagen, Denmark.
Dr Niemann received his medical degree in 2000 from Kobenhavns University, before completing a PhD in 2006. He then worked at Rigshospitalet, Copenhagen, Denmark, and Roskilde Sygehus, Roskilde, Denmark, until 2010. He then became a fellow in Hematology at Rigshospitalet. Meanwhile, he also worked as the medical secretary for the Danish Medicines Agency, Copenhagen, Denmark. Then Dr Niemann worked for the National Institutes of Health and the Danish Cancer Society, Copenhagen, Denmark, until 2015 where he resides today as a consultant at Rigshospitalet.
Speaking on CLL and CML
Dr Niemann’s research interests are focused on the development of novel therapies for CLL and CML. He is involved in clinical trials, including the VISION trial, and has been published in prestigious journals such as Blood.